 double-blind placebo-control trial eight-week cours recombin alpha-interferon chronic non-a non-b hepat forty-nin japanes patient random placebo-control double-blind trial alpha-interferon chronic non-a non-b hepat patient unit recombin human alpha alpha-interferon thrice week patient placebo similar schedul mean serum alanin aminotransferas alt SD interferon treatment unchang placebo treatment serum alt level normal rang interferon-tr patient placebo-tr patient pre- posttreat liver biopsi case averag histolog activ indic hai interferon-tr group unchang placebo group addit efficaci interferon treatment anti-hepat viru hcv antibodi posit neg group biochem histolog improv similar signific patient antibodi viru data eight-week cours alpha-interferon induc biochem histolog improv patient chronic non-a non-b hepat